MarketCap
Facebook
X
Telegram
Timber Pharmaceuticals Langfristiger Schuldenstrom | TMBR
Langfristiger Schuldenstrom Jährlich Timber Pharmaceuticals
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 331 K | 333 K | 218 K | - | - | - | - | - | - | - | - | - | - |
Jährliche Entwicklung
Kennzahlen zur Anzeige auswählen
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 333 K | 218 K | 294 K |
Langfristiger Schuldenstrom anderer Aktien in der Pharmaeinzelhändler
| Name | Langfristiger Schuldenstrom | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
 |
Replimune Group
REPL
|
1.16 M | $ 23.3 | 4.67 % | $ 2.16 B |  USA |
 |
Royalty Pharma plc
RPRX
|
380 M | $ 69.47 | 1.02 % | $ 29.9 B | USA |
 |
Revolution Medicines
RVMD
|
16.5 M | $ 193.0 | -3.57 % | $ 36.7 B | USA |
 |
Rhythm Pharmaceuticals
RYTM
|
650 K | $ 113.99 | 0.04 % | $ 7.41 B | USA |
 |
Codiak BioSciences
CDAK
|
2.66 M | - | -55.98 % | $ 2.15 M | USA |
 |
Sana Biotechnology
SANA
|
14.9 M | $ 2.43 | -1.42 % | $ 615 M | USA |
 |
Sol-Gel Technologies Ltd.
SLGL
|
495 K | $ 61.81 | 0.11 % | $ 172 M |  Israel |
 |
Summit Therapeutics
SMMT
|
3.39 M | $ 17.78 | -0.34 % | $ 13.3 B |  Britain |
 |
Syndax Pharmaceuticals
SNDX
|
470 K | $ 9.43 | -0.89 % | $ 817 M | USA |
 |
Spero Therapeutics
SPRO
|
1.96 M | $ 1.01 | -5.61 % | $ 56.6 M | USA |
 |
Sarepta Therapeutics
SRPT
|
11.2 M | $ 16.4 | -5.54 % | $ 1.64 B | USA |
 |
Tarsus Pharmaceuticals
TARS
|
608 K | $ 73.9 | 4.32 % | $ 3.09 B | USA |
 |
Bio-Techne Corporation
TECH
|
14.9 M | $ 72.83 | -0.01 % | $ 11.4 B | USA |
 |
Sage Therapeutics
SAGE
|
1.32 M | - | - | $ 527 M | USA |
 |
Taro Pharmaceutical Industries Ltd.
TARO
|
1.95 M | - | - | $ 1.62 B | Israel |
 |
Cabaletta Bio
CABA
|
3.46 M | $ 1.43 | -5.0 % | $ 144 M | USA |
 |
Forma Therapeutics Holdings
FMTX
|
5.12 M | - | - | $ 958 M | USA |
 |
Blueprint Medicines Corporation
BPMC
|
13.3 M | - | - | $ 8.14 B | USA |
 |
Horizon Therapeutics Public Limited Company
HZNP
|
7.8 M | - | - | $ 26.6 B |  Irlanda |
 |
Tonix Pharmaceuticals Holding Corp.
TNXP
|
125 K | $ 4.12 | -8.35 % | $ 35.1 M | USA |
 |
Paratek Pharmaceuticals
PRTK
|
500 K | - | - | $ 121 M | USA |
 |
DBV Technologies S.A.
DBVT
|
1.12 M | $ 11.55 | 4.52 % | $ 1.61 B |  France |
 |
Gilead Sciences
GILD
|
102 M | $ 170.68 | 0.8 % | $ 212 B | USA |
 |
Taysha Gene Therapies
TSHA
|
1.49 M | $ 4.28 | -2.06 % | $ 1.37 B | USA |
 |
ASLAN Pharmaceuticals Limited
ASLN
|
226 K | - | -14.27 % | $ 1.7 M |  Singapore |
 |
Adverum Biotechnologies
ADVM
|
5.67 M | - | - | $ 86.2 M | USA |
 |
Unity Biotechnology
UBX
|
3.83 M | - | -33.41 % | $ 3.37 M | USA |
 |
iTeos Therapeutics
ITOS
|
1.34 M | - | - | $ 411 M | USA |
 |
Gossamer Bio
GOSS
|
938 K | $ 11.2 | 5.21 % | $ 2.56 B | USA |
 |
GeoVax Labs
GOVX
|
263 K | $ 0.11 | -22.17 % | $ 105 K | USA |
 |
Seelos Therapeutics
SEEL
|
15 K | - | -47.76 % | $ 6.27 M | USA |
 |
Vericel Corporation
VCEL
|
14 M | $ 59.02 | 1.08 % | $ 2.97 B | USA |
 |
Veracyte
VCYT
|
4.05 M | $ 24.05 | -7.21 % | $ 1.89 B | USA |
 |
Advaxis
ADXS
|
166 K | - | -9.65 % | $ 45.9 M | USA |
 |
GlaxoSmithKline plc
GSK
|
137 M | $ 51.25 | -0.56 % | $ 208 B | Britain |
 |
Vir Biotechnology
VIR
|
8.8 M | $ 13.17 | -3.48 % | $ 1.82 B | USA |
 |
Viking Therapeutics
VKTX
|
137 K | $ 28.67 | -1.1 % | $ 3.23 B | USA |
 |
Vanda Pharmaceuticals
VNDA
|
2.15 M | $ 4.07 | -0.49 % | $ 240 M | USA |
 |
Verrica Pharmaceuticals
VRCA
|
341 K | $ 3.55 | -1.11 % | $ 37.8 M | USA |
 |
Vertex Pharmaceuticals Incorporated
VRTX
|
77.3 M | $ 547.74 | -0.57 % | $ 140 B | USA |
 |
Kiromic BioPharma
KRBP
|
685 K | - | 6.61 % | $ 3.08 M | USA |
 |
vTv Therapeutics
VTVT
|
169 K | $ 20.88 | -1.42 % | $ 83.8 M | USA |
 |
Voyager Therapeutics
VYGR
|
7.84 M | $ 1.82 | -8.54 % | $ 107 M | USA |
 |
Calithera Biosciences
CALA
|
1.53 M | - | -10.95 % | $ 876 K | USA |
 |
Applied Molecular Transport
AMTI
|
4.64 M | - | - | $ 10.1 M | USA |
 |
Wave Life Sciences Ltd.
WVE
|
8.36 M | $ 3.41 | -2.01 % | $ 575 M | Singapore |